Accéder au contenu
Merck

Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.

EMBO reports (2020-04-08)
Anne-Catherine Dolens, Kaat Durinck, Marieke Lavaert, Joni Van der Meulen, Imke Velghe, Jelle De Medts, Karin Weening, Juliette Roels, Katrien De Mulder, Pieter-Jan Volders, Katleen De Preter, Tessa Kerre, Bart Vandekerckhove, Georges Leclercq, Jo Vandesompele, Pieter Mestdagh, Pieter Van Vlierberghe, Frank Speleman, Tom Taghon
RÉSUMÉ

γδ and αβ T cells have unique roles in immunity and both originate in the thymus from T-lineage committed precursors through distinct but unclear mechanisms. Here, we show that Notch1 activation is more stringently required for human γδ development compared to αβ-lineage differentiation and performed paired mRNA and miRNA profiling across 11 discrete developmental stages of human T cell development in an effort to identify the potential Notch1 downstream mechanism. Our data suggest that the miR-17-92 cluster is a Notch1 target in immature thymocytes and that miR-17 can restrict BCL11B expression in these Notch-dependent T cell precursors. We show that enforced miR-17 expression promotes human γδ T cell development and, consistently, that BCL11B is absolutely required for αβ but less for γδ T cell development. This study suggests that human γδ T cell development is mediated by a stage-specific Notch-driven negative feedback loop through which miR-17 temporally restricts BCL11B expression and provides functional insights into the developmental role of the disease-associated genes BCL11B and the miR-17-92 cluster in a human context.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
MISSION® pLKO.1-puro Non-Mammalian shRNA Control Plasmid DNA, Targets no known mammalian genes
Sigma-Aldrich
MISSION® esiRNA, targeting human GATA3
Sigma-Aldrich
MISSION® esiRNA, targeting human BCL11B
Sigma-Aldrich
MISSION® esiRNA, targeting human RUNX1
Sigma-Aldrich
MISSION® esiRNA, targeting human TCF7